In last trading session, Hoth Therapeutics Inc (NASDAQ:HOTH) saw 0.42 million shares changing hands with its beta currently measuring 0.64. Company’s recent per share price level of $1.13 trading at -$0.04 or -3.42% at ring of the bell on the day assigns it a market valuation of $14.92M. That closing price of HOTH’s stock is at a discount of -236.28% from its 52-week high price of $3.80 and is indicating a premium of 48.67% from its 52-week low price of $0.58. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.88 million shares which gives us an average trading volume of 1.20 million if we extend that period to 3-months.
For Hoth Therapeutics Inc (HOTH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Hoth Therapeutics Inc (NASDAQ:HOTH) trade information
Upright in the red during last session for losing -3.42%, in the last five days HOTH remained trading in the red while hitting it’s week-highest on Tuesday, 06/24/25 when the stock touched $1.13 price level, adding 15.67% to its value on the day. Hoth Therapeutics Inc’s shares saw a change of 25.56% in year-to-date performance and have moved -6.61% in past 5-day. Hoth Therapeutics Inc (NASDAQ:HOTH) showed a performance of 33.36% in past 30-days. Number of shares sold short was 1.15 million shares which calculate 0.5 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 27.96% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 65.87% while estimates for its earnings growth in next 5 years are of 26.83%.
Hoth Therapeutics Inc (NASDAQ:HOTH)’s Major holders
Insiders are in possession of 0.50% of company’s total shares while institution are holding 2.31 percent of that, with stock having share float percentage of 2.32%. Investors also watch the number of corporate investors in a company very closely, which is 2.31% institutions for Hoth Therapeutics Inc that are currently holding shares of the company. ARMISTICE CAPITAL, LLC is the top institutional holder at HOTH for having 0.21 million shares of worth $0.19 million. And as of 2024-06-30, it was holding 3.0976 of the company’s outstanding shares.
The second largest institutional holder is UBS GROUP AG, which was holding about 43355.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.6305 of outstanding shares, having a total worth of $39409.0.
